A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

Launched by JANSSEN-CILAG LTD. · Jan 15, 2020

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants with moderate to severe Crohn's disease (CD), diagnosed at least 6 months prior to index date, as documented by the treating healthcare professional (HCP)
• • Participants with at least 6 months of continuous care in the study centre prior to index date
• • Participants who have agreed to install Care4Today® inflammatory bowel disease (C4T IBD) on their iOS or android smartphone as part of their management of CD
• • Participants providing informed written consent to participate in the study from the date of activation (including installation and linkage to HCP web interface) of the C4T IBD app on his/her smartphone
• Exclusion Criteria:
• • Participants with presence of ileorectal or ileal pouch-anal anastomosis documented in their medical records
• • Participants in remission for over 2 years as documented in their medical records
• • Participants participating in an interventional clinical trial
• • Participants participating in an observational study where the protocol interferes with the C4T study in the opinion of the principal investigator at each site
• • Participants with insufficient command of English to interact effectively with C4T IBD and complete the study questionnaires in the opinion of the principal investigator at each site
• • Participants unable or unwilling to provide their informed written consent to participate in the study